局部进展期胃癌的新辅助治疗
本文综述局部进展期胃癌新辅助治疗。中国约70%胃癌患者确诊时已处局部进展期,根治性手术为主但单纯手术或手术联合术后辅助治疗效果有限。新辅助化疗、放疗、靶向及免疫治疗可降期、消除微转移、减少术中散播和术后复发,提高根治性切除率,已成为重要治疗模式。
要点
- 中国约70%胃癌患者确诊时已处局部进展期。
- 新辅助治疗可降期、消除微转移、减少复发。
- 新辅助化疗、放疗、靶向及免疫治疗不断取得进展。
核心结论
- 新辅助治疗已成为局部进展期胃癌重要的多模式治疗组成部分。
研究设计与样本
- 本文为综述,围绕局部进展期胃癌新辅助治疗的探索与应用进行汇总。
主要发现
- 新辅助治疗具有降低肿瘤分期、减小原发灶、消除微转移、减少术中散播和术后复发、提高根治性切除率等优点。
- 化疗、放射治疗、靶向治疗、免疫治疗在局部进展期胃癌术前新辅助治疗中的探索和应用不断取得进展。
关键数值与推荐
- 中国约70%的胃癌患者确诊时已处于局部进展期。
临床怎么用
- 局部进展期胃癌以根治性手术为主要治疗方式,可考虑将新辅助治疗纳入多模式治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gastric cancer is the second most common and the second leading cause of cancer related mortality in China, which seriously endanger the lives and health of Chinese people. Due to the lack of typical symptoms and screening system of early gastric cancer, about 70% patients with gastric cancer are diagnosed as locally advanced disease in China. Radical resection is the main approach for locally advanced gastric cancer (LAGC), however, the clinical effect of gastrectomy alone or gastrectomy plus adjuvant treatment is limited. As a result, there has been increasing interest in the neoadjuvant treatment, which could potentially downstage tumor, eliminate tumor micrometastasis, reduce intraoperative dissemination and postoperative recurrence, thus improve the prognosis of patients with LAGC. The exploration and application of chemotherapy, radiotherapy, targeted therapy and immunotherapy of neoadjuvant treatment in LAGC have made continuous progress in recent years. To date, neoadjuvant therapy has been developed as a part of multimodality treatment for patients with LAGC. 胃癌位居中国恶性肿瘤发病率和死亡率第2位,严重危害国人的生命和健康。由于早期症状不典型、筛查体系不完善,中国约70%的胃癌患者确诊时已处于局部进展期。根治性手术是局部进展期胃癌最主要的治疗方式,但单纯手术治疗和传统的手术联合术后辅助治疗效果均不甚理想。术前新辅助治疗具有降低肿瘤分期、减小肿瘤原发灶、消除肿瘤微转移、减少术中散播和术后复发、提高胃癌根治性切除率等优点。近年来,化疗、放射治疗、靶向治疗、免疫治疗在局部进展期胃癌术前新辅助治疗中的探索和应用不断取得进展。新辅助治疗已成为局部进展期胃癌重要的治疗模式。.
引用
- Zhao LL, Zhao DB, Chen YT, et al. [Neoadjuvant treatment for locally advanced gastric cancer]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 33256300. doi:10.3760/cma.j.cn112152-20200521-00473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。